More articles from Original Article

You have access
SHP-1 acts as a tumor suppressor by interacting with EGFR and predicts the prognosis of human breast cancer
Qian Geng, Ruiting Xian, Yinjue Yu, Fengsheng Chen and Rong Li

Cancer Biology & Medicine April 2022, 19 (4) 468-485; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0501
You have access
Comparative profiling of immune genes improves the prognoses of lower grade gliomas
Zhiliang Wang, Wen Cheng, Zheng Zhao, Zheng Wang, Chuanbao Zhang, Guanzhang Li, Anhua Wu and Tao Jiang

Cancer Biology & Medicine April 2022, 19 (4) 533-550; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0173
You have access
Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study
Hui Lu, Shanshan Guo, Liting Liu, Qiuyan Chen, Yujing Liang, Sailan Liu, Xuesong Sun, Qingnan Tang, Xiaoyun Li, Ling Guo, Haoyuan Mo, Linquan Tang and Haiqiang Mai

Cancer Biology & Medicine April 2022, 19 (4) 551-564; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0627
You have access
PGK1-coupled HSP90 stabilizes GSK3β expression to regulate the stemness of breast cancer stem cells
Wei Tang, Yu Wu, Xin Qi, Rilei Yu, Zhimin Lu, Ao Chen, Xinglong Fan and Jing Li

Cancer Biology & Medicine April 2022, 19 (4) 486-503; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0362
You have access
Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma
Jingrong Xian, Shiwen Wang, Yanyu Jiang, Lihui Li, Lili Cai, Ping Chen, Yue Liu, Xiaofei Zeng, Guoan Chen, Chen Ding, Robert M. Hoffman, Lijun Jia, Hu Zhao and Yanmei Zhang

Cancer Biology & Medicine April 2022, 19 (4) 504-517; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0484
You have access
Is adjuvant chemotherapy necessary for early gastric cancer?
Yu Mei, Tienan Feng, Min Yan, Zhenggang Zhu and Zhenglun Zhu

Cancer Biology & Medicine April 2022, 19 (4) 518-532; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0636
You have access
Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding

Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
You have access
Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian

Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
You have access
Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie

Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
You have access
SNORA23 inhibits HCC tumorigenesis by impairing the 2′-O-ribose methylation level of 28S rRNA
Zhiyong Liu, Yanan Pang, Yin Jia, Qin Qin, Rui Wang, Wei Li, Jie Jing, Haidong Liu and Shanrong Liu

Cancer Biology & Medicine January 2022, 19 (1) 104-119; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0343

Main menu

User menu

Search

More articles from Original Article

Pages

Navigate

More Information

For Authors

Journal Services